• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Stevenage Bioscience Catalyst Wins the UK’s PING Innovation Award

Article

The UK’s Stevenage Bioscience Catalyst,1 a globally recognized cluster for therapeutic research and development providing support for translation and commercialization of innovative new medicines, won the 2021 PING Innovation Award in November.

The PING Innovation Awardrecognizes individuals and organizations whose innovative ideas, products, services or processes in the pharma sector are making a positive impact on people‘s lives.

Dr. Sally Ann Forsyth OBE, CEO of Stevenage Bioscience Catalyst commented, “It is a pleasure to receive this award on behalf of Stevenage Bioscience Catalyst. On campus we have created a vibrant ecosystem that brings academics, entrepreneurs and major corporates together in a collaborative and supportive environment that helps companies to grow. I would like to thank VWV for the award, all our partners and collaborators who have provided outstanding support and the SBC team for their tireless efforts to create the globally recognized cluster we see today.”

Paul Gershlick, Chair of PING and Head of Pharmaceuticals and Life Sciences at the law firm VWV, praised the winner. "We heard a lot at the recent 2021 PING Conference — led by VWV in conjunction with IQVIA3 and supported by Hertfordshire Local Enterprise Partnership4 — about innovation and collaboration, and Stevenage Bioscience Catalyst ticks both boxes. The campus was certainly innovative when it opened, and its building and design were made with collaboration in mind. What it has achieved in a relatively short space of time makes it a very worthy winner — not only for being instrumental in the location of the pioneering Cell and Gene Therapy Catapult, but also for helping other exciting early-stage life sciences companies build the platform to grow and develop.”

Previous winners of the PING Innovation Award include Cell and Gene Therapy Catapult, Dr Harry Destecroix of Ziylo, Paul Strickland Scanner Centre, Sigma Pharmaceuticals Plc, the University of Hertfordshire, Proteus Digital Health and Leslie Morgan of Durbin Plc.

Read more about the PING Innovation Award 2021 winner here.

Notes

  1. https://www.stevenagecatalyst.com
  2. https://www.vwv.co.uk/law-sector/pharmaceutical-law-life-sciences/ping
  3. https://www.iqvia.com/locations/united-kingdom
  4. https://www.hertfordshirelep.com

Contact details

Main author:

Name: Paul Gershlick

Job title: PING Chair, Partner and Head of Pharmaceuticals and Life Sciences sector

Address: VWV Watford - 45 Clarendon Rd, Watford WD17 1SZ

Telephone: 01923 919 320

Mobile: 07795 570 072

Email: pgershlick@vwv.co.uk

Author support:

Name: Sandeep Saib

Job title: Marketing and Business Development Executive

Address: VWV London - 24 King William Street, London EC4R 9AT

Telephone: 020 7665 0964

Email: ssaib@vwv.co.uk

Recent Videos
Related Content